Degenerative and secondary Parkinsonian disorders (for example from carbon monoxide) are all associated with major structural pathology within or directly affecting the basal ganglia. Drug-induced states are the exception; but here elderly patients are often indistinguishable from Parkinson's disease, and some are likely to be vulnerable to neuroleptics because of mild Lewy body neuronal degeneration in the substantia nigra.' 2 Consequently drug-induced Parkinsonian states probably show nigral Lewy bodies more frequently than the normal population. In contrast, some forms of dystonia3 and chorea4 have not been linked to a particular pathological abnormality. In drug-related dyskinesia non-specific nigral degeneration might contribute to susceptibility.5 In other cases of idiopathic and drug-related tardive dyskinesia degenerative changes in one or more of the following locations have been reported; caudate nucleus, putamen, pallidum, substantia nigra and inferior olive;6 but these findings are not consistent or necessarily excessive for age-related effects. Four cases of drug-induced dyskinesia apparently showed abnormally inflated neurons in the dentate nucleus.6 (IDIOPATHIC) LEWY BODY DISEASE In 1969 Forno introduced the phrase "incidental Lewy body cases" when describing 50 brains from persons dying without Parkinson's disease, but in which Lewy bodies were present in the locus coeruleus, substantia nigra, and in other locations characteristic of Parkinson's disease. 27 Consequently she proposed that they represented early or preclinical cases rather than a manifestion of normal ageing. 7 The term "Lewy body disease" was then introduced to describe the common pathological substrate of incidental cases and Parkinson's disease. 8 The word "diffuse"9 was added, giving "diffuse Lewy body disease", to describe patients in whom the degenerative process with Lewy bodies appeared to spread with unusual severity into limbic areas and cerebral cortex, associated with dementia with or without Parkinson's disease.'0 A number of terms have thus emerged but do these refer to the same basic disorder or not? Diffuse Lewy body disease intentionally suggests a distinct disease entity, but is this justified?'"1 The following discussion will attempt to clarify this area by describing the spectrum of Lewy body disease.
Parkinson's disease: diagnosis and definition Encephalitis lethargica was unhelpful to the progress of neuropathology because in years subsequent to the epidemic it proved impossible to distinguish consistently the lesions of post-encephalitic and idiopathic Parkinsonian states by clinical and pathological study. Encephalitis lethargica pointed to the substantia nigra as a major site of damage in Parkinsonian states, but this was not generally acknowledged until 1938."2 In the 1950s Lewy bodies in the substantia nigra were linked to idiopathic cases, and neurofibrillary tangles with post-encephalitic patients, but it is well-known that many patients without a history of encephalitis lethargica, some of whom had subclinical disease, and some labelled "idiopathic" encephalitis, do not 56 invariably show Lewy bodies. In the 1960s three degenerative Parkinsonian disorders were described, which to a greater or lesser extent resembled Parkinson's disease clinically: striatonigral degeneration,'3 Steele-Richardson-Olszewski syndrome'4 and corticobasal degeneration.'5 Despite this clarification there were other disorders resembling Parkinson's disease, but without Lewy bodies; they were designated as idiopathic Alzheimer tangle disease or extranigral cases,8 thus raising persistent doubt over the relevance of the Lewy body to Parkinson's disease. However, recently Lewy bodies have been found in the substantia nigra in the majority of patients believed to have established Parkinson's disease.'6 Where they cannot be identified there is always other structural pathology outside the substantia nigra, usually conforming to striatonigral degeneration or SteeleRichardson-Olszewski syndrome, assuming that druginduced cases have been excluded. '6 In Parkinson's disease Lewy bodies are always sufficiently numerous to be found within surviving nigral neurons in two 7 pm-thick, unilateral, midbrain sections. This is due to their relative frequency and also to the substantial number of neurons (approximately 25% of normal) that remain. Unlike postencephalitic Parkinsonian syndrome and some examples of striatonigral degeneration and SteeleRichardson-Olszewski syndrome the neuronal loss is never complete despite durations of clinical disease in excess of 20 years. The power of the Lewy body is to exclude Parkinson's disease if absent in two nigral sections, 330 pigmented nigral nerve cells, or 150 pigmented nerve cells in the locus coeruleus.'6 Lewy bodies also exist as in Forno's incidental cases, or coincidentally with an alternative pathology responsible for the Parkinsonian state, or in corticobasal degeneration and Hallervorden-Spatz disease, more or less often than once every 330 nigral nerve cells. These situations not infrequently lead to misdiagnosis. Consequently, a diagnosis of Parkinson's disease also depends on depletion of nerve cells in the substantia nigra by 60%, and the exclusion of other Parkinsonian disorders.
Lewy bodies are also found in specific extranigral sites in Parkinson's disease, mostly in medium to large monoaminergic and cholinergic neurons, and throughout the autonomic nervous system (table 1) . They are present in many smaller nuclear groups, for example in the mibrain region, the intracapsular nucleus of the ventral tegmentum and pedunculopontine neurons are included. It is sometimes erroneously stated that in Lewy body disease they occur in the striatum, pallidum, subthalamic nucleus, motor cranial nerve nuclei (hypoglossal), and pontine nuclei. The same Lewy body disease is thus responsible for incidental or presymptomatic cases (the majority), Parkinson's disease as the commonest clinical presentation, and dementia or autonomic failure, depending on the regional emphasis of damage. The term diffuse Lewy body disease, describing patients with dementia and multiple cortical Lewy bodies, is misleading. These patients are not otherwise known to be different from the rest of the population with Lewy body disease. There is no association with severe Lewy body disease in other regions, and Lewy bodies do not occur "diffusely" in any part of the nervous system. The most accurate descriptive information in (idiopathic) Lewy body disease is provided by the terms (brainstem) Lewy body Parkinson's disease, cortical Lewy body dementia and Lewy body autonomic failure. Hallervorden-Spatz disease" Rigidity, dystonia, pyramidal signs, dementia, + / -retinitis pigmentosa-most reported are young-onset-autosomal recessive and sporadic. Variants: mentally retarded-adult-onset-sporadic-with neurofibrillary pathology' Adult-onset-autosomal dominant" Dentatorubropallidoluysian degeneration5' Ataxia, chorea, dementia, dystonia, gaze palsy-wide age range of onset-autosomal dominant and sporadic Variants; ataxia, chorea, dysarthria-onset in 2nd and 3rd decades-autosomal dominant with extended pathology59
Solitary case, age 41, dementia, somnolence, ataxia, rigidity, gaze palsy, death at 43-degeneration extending to substantia nigra and dorsomedial nucleus of thalamus, with eosinophilic bodies in striatum, thalamus and cerebral cortex"0 Pallidonigroluysian atrophy6' b3 Akinesia, rigidity-adult-onset-sporadic Variants; akinesia, cervical rigidity, upgaze palsy-sporadic-with degeneration of the centrum medianum'
Solitary case-akinesia, cervical and limb rigidity, upgaze palsy-multiple corpora amylacea in pallidum, nigra, cerebral and cerebellar white matter65
Akinesia, generalised rigidity and motor neurone disease"667 Distal axonal spheroids are a universal feature in the nucleus gracilis in middle-aged and elderly persons. They are also numerous in the nucleus cuneatus and are occasionally seen in the spinal cord, medial segment of the globus pallidus and substantia nigra, although their frequency in the latter sites has probably been overestimated." Occasionally, mild neuronal degeneration in the medial pallidum and focal damage in the substantia nigra zona compacta, accompanied by spheroids and concretions of melanin, are found in healthy persons. The significance of this process is unclear, but it is distinct from the moderately diffuse and mild loss of nigral pigmented neurons normally starting about the age of 40 years. Axonal spheroids 59 are present in a variety of diseases and can be induced experimentally, so their existence is not exclusive to Hallervorden-Spatz disease.
Hallervorden-Spatz disease The neuroaxonal dystrophies, which include Hallervorden-Spatz disease, refer to numerous spheroids and substantial neuronal degeneration, usually dispersed outside regions affected by ageing, in the absence of an alternative aetiology. The spheroids occur throughout nerve cell processes, and. some elements may be found in neuronal perikarya, but they are more often sited in distal axons. Ultrastructurally their content varies little and consists of various organelles, normal and swollen mitochondria, vesicles, dense granules, neurofilaments, microtubules and tubulomembranous structures. Mature spheroids with dense cores contain electron dense homogeneous matter. In Hallervorden-Spatz disease spheroids, lipofuscin or melanin pigment deposits (ranging from granules to concretions), and other calcium and iron positive concretions fill the pallidum, especially the medial segment, and much of the substantia nigra (figs 1 and 2)." 7 Spheroids are also found in other parts of the nervous system. The severity of damage to the substantia nigra zona compacta is often understated and the iron deposition overstated.
The majority of cases show onset in the first and second decades and manifest rigidity, dystonia, chorea, tremor, pyramidal signs, epilepsy, dementia and retinitis pigmentosa. Autosomal recessive inheritance is often apparent, and in some 15% of solitary cases there is parental consanguineity. Combinations of a Parkinsonian syndrome, dystonia and dementia are presenting features in adults.7778 Relative restriction ofpathology to the pallidum is occasionally seen,76 and tangles have been described as a prominent pathological feature. 56 the substantia nigra and locus coeruleus. The pallidal degeneration varies in severity, is most severe in the lateral segment, and may be associated with scattered pigment deposition.
Variants have been described: an autosomal dominant pattern ofdysarthria, ataxia and chorea with onset in second and third decades. 59 In addition to dentatorubropallidoluysian atrophy the one necropsied case apparently showed degeneration ofthe substantia Gibb nigra, the centromedian thalamic nucleus, optic tracts, parts of the spinal cord, anterior horn cells and other less substantial locations. 59 The internal pallidum showed gliosis but little neuronal loss.
Pallidonigroluysian atrophy Contamin et al6' described a man with akinesia and "hypertonia" showing moderate neuronal loss and gliosis apparently in the pallidum, substantia nigra, and subthalamic nucleus. Severe akinesia, a Parkinsonian gait, cervical rigidity and upgaze palsy, resembled Steele-Richardson-Olszewski syndrome, and were seen in two unrelated persons aged 61 and 64 years at onset, with durations of 5 and 7 years.' The pallidum and substantia nigra zona compacta showed degeneration with deposition of pigment and spheroids, and there was gliosis and neuronal loss in the centrum medianum, periaqueductal grey area and superior colliculus. The spheroid ultrastructure was oddly different from neuroaxonal spheroids and consisted of filaments and dense collections of granules. group.bmj.com on July 7, 2017 -Published by http://jnnp.bmj.com/ Downloaded from Neuropathology in movement disorders Kosaka et al65 described an almost identical man dying aged 67, additionally with severe limb muscle rigidity. Levodopa had a transient effect on akinesia and rigidity. There was a little gliosis in the lateral part of the ventrolateral nucleus ofthe thalamus, with a few spheroids and many corpora amylacea in the substantia nigra and pallidum, in addition to their usual sites.
Gray et al P 67 described two unrelated patients with identical pathological lesions. The first developed an unsteady gait, chorea and torticollis from age 29 years, followed by proximal limb weakness, muscle wasting and fasciculation, and a course of six years.' The maternal grandmother died at age 30 years with a Parkinsonian disorder. The second case had rigidity, bradykinesia, postural imbalance, and motor neuron disease with onset at age 32 and a duration of two years.67 A maternal uncle developed a Parkinsonian syndrome at age 45. Neuronal loss and gliosis were most severe in the subthalamic nuclei, followed by the pallidum, and lastly the substantia nigra where the changes were not as severe. There was neuronal loss affecting the hypoglossal nuclei and anterior horn cells 61 with demyelination of corticospinal tracts. The striatum, thalamus and locus coeruleus were free of lesions.
In these patients, described as pallidonigroluysian atrophies the pallidum has been diffusely involved with emphasis on either the internal65 or external63 segment.
Pallidonigral degeneration This category is very small, and may not constitute a separate disorder. The case of Serratrice et al8 was said to show normal subthalamic nuclei, and shows some overlap with motor neuron disease. The two pathological reports of van Bogaert82 and Davison83 have often been cited as examples of pallidonigral degeneration, but pallidal changes were mild, and it is not possible to classify the cases. In one ofthe patients, symptoms of rigidity, tremor and postural instability started at age 7, and she lived to early adult life.82 In the second case right arm tremor started at age 10 years, followed by progressive rigidity, akinesia and rest tremor from age 27 (table 2) . These patients are difficult to distinguish from older Parkinson's disease patients, but a high familial incidence has been reported ("paralysis agitans juvenilis familiaris").98 For the purpose of this review the category covers the few existing clinical and pathological studies on familial Parkinsonian syndromes, mostly with disease onset over age 20 years. Only pure Parkinsonian disorders are covered, with the exception of dementia in a few. Disorders showing additional features such as motor neuron disease or peripheral neuropathy are excluded. The age distinction is also arbitrary and there is overlap with juvenile cases, but it is based on the assumption that familial cases at this age are unlikely to have Parkinson's disease. However, some families have two, and rarely more, members with an adult-onset syndrome likely to be Parkinson's disease.
One of the early reports on familial Parkinsonian disorders was that of Bury,"5 who described a brother and sister, with disease starting at ages 35 and 18 years, and responding to hyoscine. He was unable to confirm that two sisters died of the disorder aged 16 and 26 years. Spellman"6 described a family with eight affected members in three generations, with onset between ages 26 and 45 years and death 2 to 12 years later. Davison83 described four individuals all with extensor plantar responses. One occurred sporadically with onset at 24 years. In another, parents were consanguineous, onset was at 24 years and a sister probably had the same disease starting at 22 years. The third and fourth cases were siblings, aged 17 and 18 years at onset, of consanguineous parents. Yamamura et al"7 described 15 cases, aged 13 to 28 at onset (four younger than age 20 at onset), from eight families. Two families, each with two affected siblings, showed parental consanguineity. Remaining families had two to four affected siblings. The affected offspring of consanguineous marriages83 105 117 presumably reflect autosomal recessive inheritance. Although ages of onset are generally higher, this disease might be identical to juvenile Parkinsonian disorder.
Muenter et al14 described a family of 12 individuals spanning four generations (similar to Spellman's"6) that suffered a Parkinsonian disorder, followed by dementia, starting in the second or third decades and lasting 4 to 11 years. Neuropathological findings showed Lewy bodies in the usual specific areas, including limbic regions. Golbe et al (abstract) reported a large Italian family with many members afflicted with a Parkinsonian disorder, but no dementia, starting between 32 and 68 years with an approximate survival of 6 5 years. Lewy bodies were present in pigmented brainstem nuclei. These two families indicate an autosomal dominant Lewy body disease.
Two additional families do not accord with this 
